A Phase 2 Trial of KIR-Mismatched Unrelated Donor Transplantation Using in Vivo T Cell Depletion with Antithymocyte Globulin in Acute Myelogenous Leukemia: Children's Oncology Group AAML05P1 Study-Reference-Cited by-同舟云学术

A Phase 2 Trial of KIR-Mismatched Unrelated Donor Transplantation Using in Vivo T Cell Depletion with Antithymocyte Globulin in Acute Myelogenous Leukemia: Children's Oncology Group AAML05P1 Study

Published:2020-04 Issue:4 Volume:26 Page:712-717
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Davies Stella M.,Iannone Robert,Alonzo Todd A.,Wang Yi-Cheng,Gerbing Robert,Soni Sandeep,Kolb E. Anders,Meshinchi Soheil,Orchard Paul J.,Burns Linda J.,Shenoy Shalini,Leung Wing

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference20 articles.

1. What is a natural killer cell?;Moretta;Nat Immunol,2002

2. NK cell recognition;Lanier;Annu Rev Immunol,2005

3. Interplay of natural killer cells and their receptors with the adaptive immune response;Raulet;Nat Immunol,2004

4. Interactions between NK cells and B lymphocytes;Yuan;Adv Immunol,2004

5. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants;Ruggeri;Science,2002

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Navigating Treatment Options and Communication in Relapsed Pediatric AML;American Society of Clinical Oncology Educational Book;2024-06

2. A higher CD34 + cell dose correlates with better event-free survival after KIR-ligand mismatched cord blood transplantation for childhood acute myeloid leukemia;Journal of Hematology & Oncology;2024-04-29

3. Increased donor inhibitory KIR are associated with reduced GVHD and improved survival following HLA‐matched unrelated donor HCT in paediatric acute leukaemia;British Journal of Haematology;2024-03-05

4. Increased Donor Inhibitory KIR Are Associated with Reduced GVHD and Improved Survival Following HLA Matched Unrelated Donor HCT in Pediatric Acute Leukemia;2023-12-15

5. Treatment of recurrent pediatric myelodysplastic syndrome post hematopoietic stem cell transplantation;Clinical Case Reports;2023-11